Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

From the monthly archives: November 2020

We are pleased to present below all posts archived in 'November 2020'. If you still can't find what you are looking for, try using the search box.

The Biosphere: Pioneering biotech start-up looking to tackle global donor tissue shortages joins growing life science cluster on Newcastle Helix

A biotech start-up, whose technology aims to tackle cornea donor tissue shortages and speed up life-changing transplants worldwide, has moved into a specialist lab facility – The Biosphere on Newcastle Helix.

Read the rest of entry »

University of Birmingham Enterprise: ‘Rapid science’ makes custom-fitted facemasks for NHS workers

A company working with experts from the University of Birmingham and King’s College London has been awarded funding by Innovate UK to produce custom-fitted, reusable, medical grade facemasks that will fit all people regardless of age, sex or ethnicity.  

Read the rest of entry »

University of Birminigham Enterprise: Helicates meet Rotaxanes to create promise for future disease treatment

23 November 2020:  A new approach to treating cancers and other diseases that uses a mechanically interlocked molecule as a ‘magic bullet’ has been designed by researchers at the University of Birmingham.

Read the rest of entry »

University of Birmingham Enterprise: Magnetic brain waves to detect injury and disease

23 November 2020:  Scientists at the University of Birmingham have developed a new sensor to measure weak magnetic signals in the brain, which has the potential to increase understanding of connectivity in the brain, and detect signs of traumatic brain injury, dementia and schizophrenia. 

Read the rest of entry »

University of Birmingham Enterprise: Anti-COVID-19 nasal spray formulated at University of Birmingham, UK is ‘ready for use in humans’

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using materials already cleared for use in humans. 

Read the rest of entry »

Inivata Appoints Dr. Alan Schafer as Chief Technology Officer

Inivata, a leader in liquid biopsy, today announces the appointment of Dr. Alan Schafer as Chief Technology Officer (CTO), effective immediately. Alan will lead the development of Inivata’s leading InVision® liquid biopsy technology platform and new product development.

Read the rest of entry »

Tissue Solutions: Leading Scottish Biotech Group Launches Clinical Trials Facility to Boost Global Operations

Key player in the biotech industry and a multimillion-pound Scottish success story, the Intelligent Tissue Group (ITG) has launched Intelligent Clinical – a clinical trials facility set up to assess the safety and effectiveness of new treatments and health-related products by pharmaceutical, medical device and food manufacturing companies.

Read the rest of entry »

AMSBIO: Safeguarding Organoids Through Lockdown


AMSBIO reports how the internationally renowned Hans Clevers Lab at the Hubrecht Institute, Netherlands used their CELLBANKER® reagent when they needed to freeze down their organoids at short notice ahead of the COVID-19 spring lockdown.

Read the rest of entry »

TBAT Innovation Ltd welcomes New Team Members

TBAT Innovation Ltd are proud to welcome 5 new members to their team and celebrate their continued growth throughout this pandemic.

Read the rest of entry »

Domainex: APEIRON Biologics AG and Domainex Ltd announce the expansion of their partnership to progress targeted cancer immune therapy drug discovery

APEIRON Biologics AG, a privately-held biotech company developing breakthrough therapies to treat cancer and respiratory conditions, has selected Domainex Ltd to provide integrated lead optimisation services in order to advance the development of inhibitors for the E3 ubiquitin ligase Cbl-b through small molecule drug discovery.

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.